ResearcherZhongnan Hospital of Wuhan UniversityNo recent work listed

Lei Yang

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0009-0009-6678-9255; OpenAlex author ID A5100309494.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 1

Papers, trials and grants by year

2023: 1 paper

Papers 1

The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective stud… First author DOI 10.1186/s12957-023-02896-z ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Fuxiang Zhou · 1 shared paper, 2023
- Paper The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic… DOI 10.1186/s12957-023-02896-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.